| # | Drug | Count |
|---|---|---|
| 0 | OMEPRAZOLE MAGNESIUM | 39 |
| 1 | ASPIRIN | 37 |
| 2 | ASPIRIN 325 MG | 37 |
| 3 | ASPIRIN 81 MG | 37 |
| 4 | METFORMIN | 35 |
| 5 | METFORMIN ER 500 MG | 35 |
| 6 | METFORMIN ER 750 MG | 35 |
| 7 | OMEPRAZOLE | 34 |
| 8 | BISOPROLOL FUMARATE | 27 |
| 9 | ROSUVASTATIN | 27 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BEXAGLIFLOZIN | 1 | 0.0323 |
| 1 | AMILORIDE HYDROCHLORIDE | 4 | 0.0047 |
| 2 | ZIV-AFLIBERCEPT | 3 | 0.0023 |
| 3 | AMINOPHYLLINE | 4 | 0.0020 |
| 4 | BETAXOLOL HYDROCHLORIDE | 1 | 0.0019 |
| 5 | METHYLERGONOVINE MALEATE | 1 | 0.0016 |
| 6 | DORAVIRINE | 1 | 0.0013 |
| 7 | BETAXOLOL | 1 | 0.0012 |
| 8 | OLEZARSEN SODIUM | 1 | 0.0011 |
| 9 | VOCLOSPORIN | 10 | 0.0010 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anti-anginal [EPC] | 8 | 0.0008 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 13 | 0.0007 |
| 2 | Hydrolytic Lysosomal Neutral Glycosphingolipid-specific Enzyme [EPC] | 5 | 0.0005 |
| 3 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 16 | 0.0005 |
| 4 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 5 | Sigma-1 Agonist [EPC] | 4 | 0.0005 |
| 6 | Antimetabolite Immunosuppressant [EPC] | 8 | 0.0004 |
| 7 | Cytochrome P450 3A Inhibitor [EPC] | 19 | 0.0003 |
| 8 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 34 | 0.0003 |
| 9 | Protease Inhibitor [EPC] | 12 | 0.0003 |